Clinical trials
Clinical Study clinical trials
Below are recruiting clinical study clinical trials, each written for real people, not researchers. We’re tracking 1,798 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05734287Recruiting
Study of causes of high male-hormone signs in young women
This study looks at how common polycystic ovary syndrome (PCOS) is among young women who have “high male-hormone” symptoms. It may help doctors better understand what condition is most likely behind those symptoms in your age group.
DohaAges 15–35 - NCT07600736RecruitingPhase 2
Safety study of ABS-1230 for children with KCNT1 epilepsy
This trial tests a new drug called ABS-1230 in children and young adults with KCNT1-related epilepsy, a rare genetic form of epilepsy. The study will check if the drug is safe and if it helps reduce seizures.
Hackensack, New JerseyAges 1 month–21 years - NCT07633158Recruiting
Real-world study of tezepelumab for chronic nasal polyps
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
HamburgAges 18–130 - NCT06419205RecruitingPhase 2
ADX-097 for IgA nephropathy, lupus nephritis, or C3G
This study tests an experimental oral therapy called ADX-097 for people with three types of kidney disease: IgA nephropathy, lupus nephritis, or C3 glomerulopathy. The goal is to see if it’s safe and can help reduce kidney damage.
Lawrenceville, GeorgiaAges 16 years+ - NCT07149701Recruiting
Ventricular Tachycardia patient registry study
This study is for adults with ventricular tachycardia (a fast heart rhythm) who also have structural heart disease. It will track your health over time to learn more about how this condition is managed.
BeijingAges 18 years+ - NCT06052553Recruiting
TopSpin360 Training Device for hockey players
This study tests a training device called TopSpin360 that might help ice hockey players improve their skills. It looks at how the device affects your brain and body while you skate.
Rochester, MinnesotaAges 18–21 - NCT07288515Recruiting
Acalabrutinib for CLL in routine care
This study follows people with CLL who are starting acalabrutinib (a targeted pill) for the first time, either as their first treatment or after previous therapies. The goal is to see how well it works in everyday medical practice.
GrodnoAges 18 years+ - NCT03188874Recruiting
Registry study for adults with AML and collected samples
This study enrolls adults with acute myeloid leukemia (AML) to build a detailed registry and store biological samples. It helps researchers understand AML better and may support future studies.
Baden-Baden, Baden-WurttembergAges 18 years+ - NCT04312633Recruiting
Testing a new throat biopsy mapping method for Barrett’s disease
This study follows people for 5 years to see how well a new biopsy-mapping test (WATS3D) works during routine upper endoscopy. It may help doctors find Barrett’s esophagus changes earlier and better guide follow-up after treatment.
Bethpage, New YorkAges 18 years+ - NCT05018481RecruitingEarly Phase 1
Study for moderate alcoholic hepatitis after heavy drinking
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
Cleveland, OhioAges 21–65 - NCT05025865RecruitingEarly Phase 1
Study of reducing alcohol use with the HA35 supplement
This early-phase study tests HA35 in people who currently drink less alcohol than typical weekly drinking limits. It aims to see whether the supplement is safe and whether it affects the body in people who are not heavy drinkers.
Cleveland, OhioAges 21–65 - NCT05371964RecruitingPhase 1
Imetelstat plus ruxolitinib for myelofibrosis patients
This Phase 1 study tests whether imetelstat combined with ruxolitinib is safe and may improve disease activity in people with myelofibrosis. It is aimed at people who need symptom control and may be taking (or considered for) ruxolitinib.
Duarte, CaliforniaAges 18 years+ - NCT05485649Recruiting
Pregnant people with epilepsy followed at a Toronto clinic
This study follows pregnant people who have epilepsy who were seen at a specific Toronto epilepsy clinic over a set time period. It aims to learn about health outcomes during pregnancy, which may help improve care and planning for future patients.
Toronto, OntarioAges Any age - NCT05780099Recruiting
Study of patients treated in internal medicine clinics
This observational study follows people receiving care in Internal Medicine at San Raffaele Hospital to better understand what kinds of conditions they have. It does not test a new treatment, but your information may help improve future care.
MilanAges 18 years+ - NCT06123897Recruiting
Schizophrenia database and biobank study
This study builds a database and collects samples (like blood) from people with schizophrenia to learn more about the condition. If you join, you help researchers understand schizophrenia better, which may lead to improved treatments.
Hefei, AnhuiAges Any age - NCT06334588Recruiting
Autism brain study using MRI and social thinking tasks
This study uses MRI brain scans (already needed for medical reasons) to better understand how autism affects social thinking. It compares people with autism to healthy volunteers to see differences in brain activity.
ParisAges 3 months–28 years - NCT06431594RecruitingPhase 1
Study of a new drug for advanced solid tumors
This trial tests a new drug called Mocertatug Rezetecan for people with advanced solid tumors that have stopped responding to standard treatments. It targets a protein called B7-H4 on cancer cells to try to slow or shrink the tumor.
Birmingham, AlabamaAges 18 years+ - NCT06770062Recruiting
How the heart changes after mitral valve repair surgery
This study at Mayo Clinic uses MRI and other tests to see how the heart's main pumping chamber changes shape after robot-assisted mitral valve repair surgery for severe mitral regurgitation. It may help doctors better understand how patients recover.
Rochester, MinnesotaAges 18 years+ - NCT06775262Recruiting
chronic fatigue in internal medicine patients
This study looks at people with chronic fatigue who saw a doctor but no physical cause was found. It aims to understand their experiences better.
Almere Stad, FlevolandAges 18 years+ - NCT07309614RecruitingPhase 3
Dupilumab for asthma remission study
This trial tests whether dupilumab can help people with moderate-to-severe asthma achieve clinical remission. It may be an option if you have asthma with high levels of certain inflammatory markers and have had at least one asthma attack in the last 2 years.
Nedlands, Western AustraliaAges 18–79 - NCT01252485Recruiting
Biology and outcome registry for acute leukemia patients
This is a research registry that collects information and lab/blood sample data to better understand what acute leukemia looks like biologically and how patients do over time. It may help future treatment decisions, but it does not describe testing a new drug.
GrazAges 18 years+ - NCT07510776Recruiting
Understanding long-term critical illness
This study looks closely at patients who stay in the ICU for 5 days or more to understand why some people recover more slowly. It may help doctors find better ways to support you during and after a long ICU stay.
Lisbon, Lisbon DistrictAges 18 years+ - NCT07634575Enrolling by invitation
Smart imaging for newly diagnosed brain cancer
This study tests whether imaging scans can be timed based on your symptoms and progress, rather than on a fixed schedule. The goal is to make monitoring easier while keeping you safe during standard brain cancer treatment.
LondonAges 18 years+ - NCT06666933Enrolling by invitation
Time-restricted eating for PCOS with glucose issues during IVF
This study tests whether a time-restricted eating plan (eating only during certain hours of the day) can improve pregnancy rates in women with PCOS and glucose metabolism problems who are undergoing IVF. The goal is to see if this eating pattern helps your body respond better to treatment.
Shanghai, Shanghai MunicipalityAges 20–38
Hear when a new Clinical Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical study?
- Yes. Clin2 currently lists 1,798 recruiting clinical study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.